Ann: Change of Director's Interest Notice-SRX.AX, page-33

First 33 Last

Share
Profile

Follow
cafa

8,917 Posts.

32

02/11/16

19:48

Post #: 20323421
Share

Originally posted by slc4me ↑

Think I have broken the rules of HC by the below post - don't care to be honest. I got angrier and angrier as I was typing so had to cut it short as I might have said something I should not have (or sounded like JCoure!!!!).

Anyway my email below:

Dear Mr Duthy,

I am a long term share holder of Sirtex and would like to express my disappointment at the Change of Directors Interest Notice released on the 1st of November. While it is obviously reasonable for Gilman Wong to sell shares the timing and lack of disclosure as to why is very perplexing.

To be selling shares so soon after the AGM suggests to me Mr Wong has little faith in the future performance of SRX. If Mr Wong has little faith it raises the question as to why should I have any faith in the long term future of SRX. The selling of shares by Mr Wong has been compounded by the refusal of the company to release a forecast for this financial year and an update of the 1st qtr sales. I note Mr Wong has sold shares in the past but this was done at a time when quarterly sales were also disclosed - so at least all shareholders (not just a select few) - knew how the company was performing.

I also find it disturbing that a reason was not given with the change of interest notice (not required but many other companies do) and a $ value received (legally required so the form should be released again with the consideration obtained).

The bottom line is Mr Wong is telling all shareholders (only 7 days ago at the AGM) that the company is travelling well and has a bright future, while at the same time he is making significant sales of his own holdings. All this done while the company refuses to publish performance updates. This is the behaviour of a penny dreadful stock that will never amount to anything - rather than an ASX 100 listed company with a $1.6B market cap.

Sirtex is better than this. I urge the Board to seriously reconsider issuing quarterly updates or at least reduce the amount of shares a director can sell without a reasonable explanation.

A very disappointed Shareholder

Regards

Expand

Did you get a response from Duthy?

Interesting guy - spoke to him at the AGM regarding the badly worded, IMO, previous ANN about the trial and Resin. I pointed out that the trial has been in the PD for a month and thus was not that newsworthy to be the lead item in the ANN, and that the emphasis was changed when the ASN ANN was released the next day. Or the other way around - memory!

He was clearly unimpressed that I would make such an assertion and became rather defensive. So I would be curious as to his words.

SRX Price at posting: $27.20 Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BUX

Buxton projects new graphite province discovery at WA Narryer play

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

There are more pages in this discussion • 43 more messages in this thread...

First 33 Last

Add SRX (ASX) to my watchlist

Ann: Change of Director's Interest Notice-SRX.AX, page-33

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Buxton projects new graphite province discovery at WA Narryer play

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News